亚宝药业：累计回购1.14%股份

Core Viewpoint - The company, Yabao Pharmaceutical (600351.SH), has completed its share repurchase plan, indicating a strategic move to enhance shareholder value and potentially stabilize its stock price [1] Summary by Categories Share Repurchase Details - The company repurchased a total of 8 million shares, which represents 1.14% of its total share capital [1] - The highest transaction price during the repurchase was 6.65 CNY per share, while the lowest was 6.30 CNY per share [1] - The average repurchase price was 6.52 CNY per share, with a total expenditure of 52.1519 million CNY (excluding transaction fees) [1]